4.5 Article

Enzymatic synthesis of dimeric glycomimetic ligands of NK cell activation receptors

Journal

CARBOHYDRATE RESEARCH
Volume 346, Issue 12, Pages 1599-1609

Publisher

ELSEVIER SCI LTD
DOI: 10.1016/j.carres.2011.04.043

Keywords

beta-N-Acetylhexosaminidase; Galactosyltransferase; Enzymatic glycosylation; Natural killer cell; CD69; Triazole

Funding

  1. Czech Science Foundation [203/09/P024, 305/09/H008, 303/09/0477]
  2. Institute of Microbiology [AV0Z50200510]
  3. Charles University in Prague [MSM21620808]
  4. Carlsberg research Foundation
  5. Faculty of Sciences and OChem Graduate School, Aarhus University, Denmark
  6. EU ESF [COST CM 0701]
  7. Deutsche Forschungsgemeinschaft [DFG EL 135/10-1]

Ask authors/readers for more resources

This work reveals new structural relationships in the complex process of the interaction between activation receptors of natural killer cells (rat NKR-P1, human CD69) and novel bivalent carbohydrate glycomimetics. The length, glycosylation pattern and linker structure of receptor ligands were examined with respect to their ability to precipitate the receptor protein from solution, which simulates the in vivo process of receptor aggregation during NK cell activation. It was found that di-LacdiNAc triazole compounds show optimal performance, reaching up to 100% precipitation of the present protein receptors, and achieving high immunostimulatory activities without any tendency to trigger activation-induced apoptosis. In the synthesis of the compounds tested, two enzymatic approaches were applied. Whereas a beta-N-acetylhexosaminidase could only glycosylate one of the two acceptor sites available with yields below 10%, the Y284L mutant of human placental beta 1,4-galactosyltransferase-1 worked as a perfect synthetic tool, accomplishing even quantitative glycosylation at both acceptor sites and with absolute regioselectivity for the C-4 position. This work insinuates new directions for further ligand structure optimisation and demonstrates the strong synthetic potential of the mutant human placental beta 1,4-galactosyltransferase-1 in the synthesis of multivalent glycomimetics and glycomaterials. (C) 2011 Elsevier Ltd. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available